Michael Foster Green

Dr. Michael F. Green is a distinguished Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the Geffen School of Medicine at UCLA. He also serves as the Director of the Treatment Unit at the Department of Veteran Affairs VISN 22 Mental Illness Research, Education, and Clinical Center (MIRECC). With an academic journey that began with a B.A. in psychobiology from Oberlin College, Dr. Green pursued his doctorate in neuropsychology at Cornell University, followed by postdoctoral training at UCLA. Dr. Green's research is primarily focused on cognitive impairments and social cognitive dysfunction, particularly in the context of schizophrenia. His laboratory is at the forefront of exploring the intricate relationship between cognitive impairments in schizophrenia and the impact on daily living activities. His work delves into understanding the neural mechanisms underlying cognitive and social cognitive dysfunction, aiming to bridge the gap between theoretical research and practical applications. As an associate editor for the Schizophrenia Bulletin and a member of the editorial boards for Cognitive Neuropsychiatry and Schizophrenia Research, Dr. Green plays a pivotal role in shaping the discourse in his field. His prolific contributions include over 230 journal articles, supported by numerous grants from the National Institute of Mental Health (NIMH), the Veterans Administration, and various private foundations. Dr. Green's ongoing studies are pioneering efforts in evaluating social cognitive retraining and exploring novel pharmacological interventions to mitigate cognitive impairments. His commitment to advancing the understanding of schizophrenia is further reflected in his authorship of two influential books: "Schizophrenia from a Neurocognitive Perspective: Probing the Impenetrable Darkness" (1998) and "Schizophrenia Revealed: From Neurons to Social Interactions" (2001). Through his extensive research and scholarly contributions, Dr. Green continues to influence the field of neuropsychology, with a particular emphasis on improving the quality of life for individuals affected by schizophrenia. His work not only enhances academic understanding but also holds the promise of tangible benefits for clinical practices and patient outcomes.